全球代谢体学市场规模、份额、成长分析、按产品和服务、按最终应用划分 - 行业预测，2024-2031 年

Global Metabolomics Market Size, Share, Growth Analysis, By Product and service(Metabolomics Instruments, Separation Tools), By End-use(Academic and Research Institutes, Pharmaceutical & Biotechnology Companies) - Industry Forecast 2024-2031

出版日期: 2024年03月28日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年代谢体学的全球市场规模为28.3亿美元，从2023年的32亿美元成长到2031年的85.1亿美元，预测期内（2024-2031年）复合年增长率为13%，预计也将增长。

慢性病数量的增加、对个人化医疗的需求不断增长以及技术进步正在促进全球代谢体学市场的稳定成长。代谢体学市场的目标是提供资源和设备，使科学家和医疗专业人员能够了解生物系统的基本生化过程。透过研究细胞产生的代谢物，科学家可以了解疾病的根源并发现未来潜在的治疗标靶。用于疾病诊断和个体化医疗的生物标记的创建是代谢体学的进一步应用。随着核磁共振波谱和质谱等代谢物分析高通量平台的发展，代谢体学分析变得更快、更准确。由于产生的资料的数量和复杂性，代谢体学资料的解释可能很困难。慢性病盛行率的上升、对定製药物治疗的需求不断增长以及技术进步正在推动全球代谢体学市场的发展。市场面临设备价格高、标准缺失、人才缺乏等挑战。代谢体学市场有望促进政府、工业界和学术界之间的合作，以创造新的应用。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Agilent Technologies, Inc.（US）
Thermo Fisher Scientific, Inc.（US）
Shimadzu Corporation（Japan）
Waters Corporation（US）
Bruker Corporation（US）
PerkinElmer, Inc.（US）
Danaher Corporation（US）
Bio-Rad Laboratories, Inc.（US）
Metabolon, Inc.（US）
Human Metabolome Technologies, Inc.（Japan）
Agios Pharmaceuticals, Inc.（US）
LECO Corporation（US）
Biocrates Life Sciences AG（Austria）
Shimazu Europe GmbH（Germany）
Eurofins Scientific（Luxembourg）
Molecular Devices, LLC（US）
Phenomenex, Inc.（US）
Cambridge Isotope Laboratories, Inc.（US）
Sciex（US）
JEOL Ltd.（Japan）

简介目录

Product Code: SQMIG35H2164

Global Metabolomics Market size was valued at USD 2.83 Billion in 2022 and is poised to grow from USD 3.20 Billion in 2023 to USD 8.51 Billion by 2031, at a CAGR of 13 % during the forecast period (2024-2031).

The increased prevalence of chronic diseases, the growing need for personalized medication, and technological improvements have all contributed to the steady growth of the worldwide metabolomics market. The goal of the metabolomics market is to give scientists and medical professionals resources and instruments that will enable them to comprehend the fundamental biochemical processes that underlie biological systems. Scientists can learn more about the underlying causes of disease and find possible targets for future treatments by examining the metabolites that cells create. The creation of biomarkers for illness diagnosis and tailored medicine are further uses for metabolomics. Metabolomics analysis is now more faster and more accurate thanks to the development of high-throughput platforms for metabolite profiling, such as nuclear magnetic resonance spectroscopy and mass spectrometry. Because of the volume and complexity of the data generated, metabolomics data interpretation can be difficult. The rising incidence of chronic diseases, the growing need for tailored medication, and technological improvements are driving the worldwide metabolomics market. The market faces difficulties such the high price of instruments, the absence of standards, and the scarcity of qualified workers. There are plenty of prospects in the market for government, business, and academic cooperation as well as for the creation of new applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Metabolomics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Metabolomics Market Segmental Analysis

The product, application, and geographic segments of the worldwide metabolomics market are divided up. The market is divided into three segments based on the kind of product and service: metabolomics instruments, separation tools, and detection tools. The market is divided into academic and research institutions, pharmaceutical and biotechnology firms, contract research organizations, and others based on the end-use segmentation. The market is divided into five regions: Latin America, Middle East and Africa, Asia Pacific, Europe, and North America.

Drivers of the Global Metabolomics Market

The market has been significantly influenced by the ongoing developments in metabolomics technology, including mass spectrometry, NMR spectroscopy, and data analysis tools. These developments improve metabolomics analysis's sensitivity, accuracy, and throughput, allowing scientists to draw deeper conclusions from metabolomics data.

Restraints in the Global Metabolomics Market

One major obstacle to the market is the high cost of metabolomics devices, consumables, and data analysis tools. The use of metabolomics technology is restricted, especially in environments with limited resources, by the initial cost of setting up metabolomics laboratories and the continuing costs for consumables and maintenance.

Market Trends of the Global Metabolomics Market

Integrating metabolomics data with genomes, proteomics, and transcriptomics data is known as the integration of multi-omics techniques. This integration offers insights into intricate biological processes and the causes of disease, enabling a thorough understanding of biological systems. Systems biology and customized medicine are projected to advance as a result of the integration of multi-omics data.

Application of Metabolomics in Microbiome Research: The study of the metabolic interactions between host organisms and the microbial communities they are linked with is made possible by the growing application of metabolics in microbiome research. Understanding the metabolites generated by the microbiome and how they affect host health and illness is possible through metabolomics. It is anticipated that the use of metabolomics in microbiome research will spur additional advancements in the fields of microbial ecology, tailored nutrition, and gut health.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Metabolomics Market by Product and service

Market Overview
Metabolomics Instruments
Separation Tools
and Detection Tools

Global Metabolomics Market by End-use

Market Overview
Academic and Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
and other End Users

Global Metabolomics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Metabolon, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Human Metabolome Technologies, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agios Pharmaceuticals, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LECO Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocrates Life Sciences AG (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimazu Europe GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molecular Devices, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phenomenex, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cambridge Isotope Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sciex (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JEOL Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments